Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | Dr. Patrick Hugh ConwayCEO of Optum | -800,00 | 284,00k | Vente | 355,00 | 6,98k | -10,28% |
| 2026-02-23 | Mr. Thomas Edward RoosInitié | -151,78 | 42,85k | Sale to Issuer | 282,34 | 31,28k | -0,48% |
| 2026-02-23 | Mr. Timothy John NoelCEO of UnitedHealthcare Business | -123,17 | 34,78k | Sale to Issuer | 282,34 | 17,47k | -0,70% |
| 2026-02-23 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -129,45 | 36,55k | Sale to Issuer | 282,34 | 16,63k | -0,77% |
| 2026-02-23 | Ms. Erin L. McSweeneyExec. VP & CPO | -130,68 | 36,90k | Sale to Issuer | 282,34 | 15,49k | -0,84% |
| 2026-02-23 | Dr. Patrick Hugh ConwayCEO of Optum | -178,99 | 50,54k | Sale to Issuer | 282,34 | 7,78k | -2,25% |
| 2026-02-20 | Ms. Erin L. McSweeneyExec. VP & CPO | -291,82 | 84,63k | Sale to Issuer | 290,00 | 10,75k | -2,64% |
| 2026-02-20 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -443,29 | 128,55k | Sale to Issuer | 290,00 | 9,67k | -4,38% |
| 2026-02-20 | Dr. Patrick Hugh ConwayCEO of Optum | -504,55 | 146,32k | Sale to Issuer | 290,00 | 7,96k | -5,96% |
| 2026-02-20 | Mr. Timothy John NoelCEO of UnitedHealthcare Business | -464,56 | 134,72k | Sale to Issuer | 290,00 | 8,74k | -5,05% |
| 2026-02-20 | Mr. Thomas Edward RoosInitié | -326,07 | 94,56k | Sale to Issuer | 290,00 | 29,00k | -1,11% |
| 2026-02-13 | Mr. Timothy John NoelCEO of UnitedHealthcare Business | -125,62 | 36,83k | Sale to Issuer | 293,19 | 9,21k | -1,35% |
| 2026-02-13 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -212,52 | 62,31k | Sale to Issuer | 293,19 | 10,12k | -2,06% |
| 2026-02-13 | Ms. Erin L. McSweeneyExec. VP & CPO | -153,09 | 44,89k | Sale to Issuer | 293,19 | 11,04k | -1,37% |
| 2026-02-13 | Mr. Thomas Edward RoosInitié | -321,89 | 94,37k | Sale to Issuer | 293,19 | 29,33k | -1,09% |
| 2026-02-13 | Dr. Patrick Hugh ConwayCEO of Optum | -295,41 | 86,61k | Sale to Issuer | 293,19 | 8,46k | -3,37% |
| 2025-12-19 | Mr. Stephen J. HemsleyCEO & Non-Independent Non-Executive Chairman | -55,00k | 0,00 | Other Disposition | - | 1,06M | -4,95% |
| 2025-09-11 | Mr. Charles Duane BakerIndependent Director | -27,00 | 9,61k | Vente | 356,05 | 0,00 | -100,00% |
| 2025-06-10 | Dr. Patrick Hugh ConwayCEO of Optum | -589,00 | 179,65k | Vente | 305,00 | 8,76k | -6,30% |
| 2025-06-06 | Ms. Erin L. McSweeneyExec. VP & CPO | -130,43 | 39,55k | Sale to Issuer | 303,22 | 11,08k | -1,16% |
| 2025-06-05 | Dr. Patrick Hugh ConwayCEO of Optum | -827,80 | 246,08k | Sale to Issuer | 295,84 - 303,22 | 9,35k | -8,14% |
| 2025-06-03 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -115,13 | 34,68k | Sale to Issuer | 301,22 | 10,19k | -1,12% |
| 2025-06-03 | Mr. John F. RexInitié | -29,50 | 8,89k | Sale to Issuer | 301,22 | 210,56k | -0,01% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
